TX-DXP-ENTERPRISES
DXP Enterprises, Inc. (NASDAQ:DXPE), today announced it will reschedule its first quarter 2023 earnings release and conference call previously scheduled for May 10, 2023. The delay is a result of additional time required to finalize the Company's financial statements, and the Company will make a further announcement regarding the timing of the release and conference call as soon as practicable but anticipates having the call before the end of the week.
The Private Securities Litigation Reform Act of 1995 provides a “safe-harbor” for forward-looking statements. Certain information included in this press release (as well as information included in oral statements or other written statements made by or to be made by the Company) contains statements that are forward-looking. Such forward-looking information involves important risks and uncertainties that could significantly affect anticipated results in the future; and accordingly, such results may differ from those expressed in any forward-looking statement made by or on behalf of the Company. These risks and uncertainties include, but are not limited to; ability to obtain needed capital, dependence on existing management, leverage and debt service, domestic or global economic conditions, and changes in customer preferences and attitudes. For more information, review the Company's filings with the Securities and Exchange Commission.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230510005428/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
CA-PSMF3.6.2023 07:12:31 CEST | Press release
The Patient Safety Movement Foundation Concludes Its 10th Annual World Patient Safety, Science & Technology Summit
HALLYM-UNIVERSITY2.6.2023 11:01:34 CEST | Press release
Ilsong Educational Foundation Chairman Dai-Won Yoon Wins Linnaeus Medal as the First in Asia
CA-PSMF2.6.2023 08:16:30 CEST | Press release
10th Annual World Patient Safety, Science & Technology Summit Begins
AUTEL-ENERGY2.6.2023 08:01:28 CEST | Press release
Autel Energy Holds Partner Summit in Amsterdam, Mapping Out Europe Strategy
PL-BIOSCIENCE-GMBH2.6.2023 07:23:26 CEST | Press release
PL BioScience and Macopharma enter into a Patent License and Assignment Agreement regarding Human Platelet Lysate (HPL) cell culture supplements.
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom